# Analysis of T Cell Metabolism in Relapsed AML Patients With DLIs and Bicanorm Treatment

> **NCT04321161** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Freiburg** · enrollment: 10 (actual)

## Conditions studied

- Acute Myeloid Leukemia, in Relapse

## Interventions

- **DRUG:** Bicanorm

## Key facts

- **NCT ID:** NCT04321161
- **Lead sponsor:** University of Freiburg
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-25
- **Primary completion:** 2020-03-18
- **Final completion:** 2020-03-18
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04321161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04321161, "Analysis of T Cell Metabolism in Relapsed AML Patients With DLIs and Bicanorm Treatment". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04321161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*